ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,492Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 680

$985K Total Retail Price of All Prescriptions

Rank: 85 out of 680

303 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 303 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,262 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 518 411 1 1
SIMVASTATIN 475 410 2 3
OMEPRAZOLE 417 350 3 7
FUROSEMIDE 406 384 4 6
NAMENDA 384 384 5 35
DONEPEZIL HCL 340 335 6 27
GLIMEPIRIDE 327 311 7 29
CITALOPRAM HBR 306 294 8 22
HYDROCODONE-ACETAMINOPHEN 299 247 S3 9 4
LEVOTHYROXINE SODIUM 287 238 10 2
LISINOPRIL 260 227 11 5
POTASSIUM CHLORIDE 240 238 12 14
METOPROLOL TARTRATE 236 194 13 12
WARFARIN SODIUM 218 196 14 20
CLONIDINE HCL 213 151 15 36
CARVEDILOL 207 175 16 23
POLYETHYLENE GLYCOL 3350 191 152 17 62
ZOLPIDEM TARTRATE 190 146 18 17
LANTUS 181 146 19 49
ATORVASTATIN CALCIUM 173 127 20 11
CYMBALTA 163 146 21 46
NOVOLIN R 153 137 22 113
LACTULOSE 151 100 23 92
METFORMIN HCL 146 108 24 8
ESCITALOPRAM OXALATE 140 102 25 45
DIGOXIN 134 134 26 58
QUETIAPINE FUMARATE 120 115 27 64
DIOVAN 117 87 28 31
CLOPIDOGREL 116 101 29 26
TAMSULOSIN HCL 114 96 30 34
LOSARTAN POTASSIUM 112 93 31 21
PRAVASTATIN SODIUM 110 99 32 10
FLUTICASONE PROPIONATE 109 85 33 41
ALBUTEROL SULFATE 104 98 34 154
SERTRALINE HCL 103 99 35 28
PANTOPRAZOLE SODIUM 101 87 36 30
LEVOFLOXACIN 96 79 37 97
MIRTAZAPINE 94 71 38 78
NATEGLINIDE 93 82 39 224
LEVETIRACETAM 92 49 40 120
FENOFIBRATE 91 59 41 66
TORSEMIDE 90 80 42 163
AMLODIPINE BESYLATE-BENAZEPRIL 84 57 43 43
PRENATAL PLUS 84 84 43 274
MEGESTROL ACETATE 83 68 R 45 88
EXELON 82 82 46 112
FAMOTIDINE 82 73 46 89
JANUVIA 81 71 48 60
SEROQUEL 81 71 48 123
CRESTOR 78 73 50 25
TRAZODONE HCL 78 70 50 48
TRICOR 77 43 52 98
CARBIDOPA-LEVODOPA 76 63 53 117
LIPITOR 76 63 53 68
MELOXICAM 75 71 55 24
NEXIUM 73 69 56 16
LIDODERM 72 72 57 221
PLAVIX 72 63 57 39
CILOSTAZOL 72 64 57 230
RIVASTIGMINE 72 72 57 309
RANITIDINE HCL 71 58 61 56
TRAMADOL HCL 70 68 62 18
LATANOPROST 69 63 63 209
HYDROCHLOROTHIAZIDE 69 59 63 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 49 63 37
CIPROFLOXACIN HCL 68 60 66 57
METOPROLOL SUCCINATE 67 67 67 13
ALENDRONATE SODIUM 66 66 68 32
SPIRONOLACTONE 66 58 68 82
PROPRANOLOL HCL 66 43 68 145
RISPERIDONE 65 40 71 80
ISOSORBIDE MONONITRATE ER 65 54 71 59
LEXAPRO 63 51 73 128
PRANDIN 62 62 74 343
GABAPENTIN 61 46 75 15
AZITHROMYCIN 60 47 76 42
GLIPIZIDE 60 44 76 63
ROPINIROLE HCL 59 46 78 99
BENAZEPRIL HCL 58 56 79 40
IPRATROPIUM-ALBUTEROL 58 57 79 207
OXCARBAZEPINE 56 22 81 304
OLANZAPINE 56 45 81 116
DIVALPROEX SODIUM 55 48 83 110
LEVOTHROID 55 44 83 368
IPRATROPIUM BROMIDE 53 51 85 211
NITROFURANTOIN MONO-MACRO 53 46 85 172
ZETIA 52 52 87 87
CLOTRIMAZOLE-BETAMETHASONE 52 48 87 138
OXYBUTYNIN CHLORIDE 52 45 87 129
ATENOLOL 51 51 90 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.